Jasper Therapeutics, Inc. is under legal scrutiny following a class action lawsuit filed by DJS Law Group. The case alleges the company violated key provisions of the Securities Exchange Act, potentially impacting the rights and investments of shareholders.
Rosen Law Firm has issued an urgent reminder for investors who purchased Altimmune shares between August 10, 2023, and June 25, 2025. The October 6, 2025 deadline to seek lead plaintiff status in a class action lawsuit could be key for those seeking compensation.
Novo Nordisk A/S shareholders who purchased their securities between May 7, 2025, and July 28, 2025, are advised by Rosen Law Firm to consider legal action. With the lead plaintiff deadline set for September 30, 2025, investors are encouraged to act promptly to secure potential compensation.
PubMatic shareholders who purchased stock between February 27, 2025, and August 11, 2025, may qualify to join a class action lawsuit over alleged securities violations. The Schall Law Firm urges investors to act by October 20, 2025.
Investors who purchased American Depositary Shares of Reckitt Benckiser between January 13, 2021, and July 28, 2024, may have the opportunity to lead a securities fraud class action lawsuit. Rosen Law Firm has filed the suit, and the deadline to move the court to serve as lead plaintiff is August 4, 2025.
Ibotta, Inc. is now under the microscope as the DJS Law Group announces an investigation into alleged securities law violations that may affect its investors. The probe could have significant implications for shareholders of the company trading under the ticker symbol IBTA.
